Memorial Sloan Kettering Cancer Center;Board of Regents, The University of Texas System
发明人:
申请号：
EP18169332.6
公开号：
EP3375791A1
申请日:
2010.09.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
